Remove companies clover-health
article thumbnail

Clover Health Stockholder Sues In Del. For Company Docs

Law 360 M&A

Another Clover Health Investments Corp. stockholder sued in Delaware Chancery Court for the company's books and records. The complaint comes a few weeks after a derivative suit alleging that the company failed to disclose a federal investigation prior to a $3.7 billion merger.

75
article thumbnail

Chamath Palihapitiya's SPAC Track Record Means Double-Digit Losses For You. Here Are The Details On All His Deals

Benzinga

Chamath Palihapitiya was one of the biggest names in the SPAC market in 2021 and when times were good for new companies going public, Palihapitiya had some of the best-performing deals of that year. Clover Health Investments (NASDAQ: CLOV ): Online health insurance. Price: $6.88. Return: -31.2%. Price: $5.20.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Del. Ruling Could Affect D&O Claims Beyond SPACs

Law 360 M&A

A Delaware state court recently held in Clover Health v.

40
article thumbnail

Gibson Dunn Offers 2022 Mid-Year Securities Litigation Update

Reynolds Holding

Lucia Companies, Inc. In Lee Enterprises , a beneficial owner of the company sought to nominate several directors as part of a takeover attempt, but it failed to comply with unambiguous advance notice bylaws requiring it to become a record holder and submit the company’s nominee questionnaire forms before the nomination deadline.

article thumbnail

Billionaire VC Chamath Palihapitiya Sells Clover Health Shares: Is He No Longer Bullish?

Benzinga

Once touted as the SPAC King, Chamath Palihapitiya used blank check companies to take several private companies public. What Happened: According to a new filing, Palihapitiya currently holds less than 5% of shares in Clover Health Investments (NASDAQ: CLOV ). The Clover Health SPAC merger was announced in October 2020.

52